Advertisement

Topics

Once More Unto The Breach: PTC's Duchenne Drug Translarna Gets Advisory Cmte.

14:10 EDT 22 Aug 2017 | SCRIP

US FDA's Peripheral and Central Nervous System Advisory Committee to consider application, which PTC Therapeutics filed over protest.

      

Related Stories

 

Original Article: Once More Unto The Breach: PTC's Duchenne Drug Translarna Gets Advisory Cmte.

NEXT ARTICLE

More From BioPortfolio on "Once More Unto The Breach: PTC's Duchenne Drug Translarna Gets Advisory Cmte."

Advertisement
Quick Search
Advertisement
Advertisement